Please assess the completion status of the following clinical trial:

Trial Title: Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* proven Crohn's disease~* Single or multiple draining perianal fistulas~Exclusion Criteria:~* Abscesses~* Infliximab, cyclosporine, tacrolimus and antibiotics for Crohn's disease within past 3 months~* active viral infection~* significate cardiovascular dysfunction~* Pregnancy, Lactation~* Surgical bowel resection to be expected within 6 months~* Positive stool culture for enteric pathogens~* Total parental nutrition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Adalimumab
- 2 (Type: PLACEBO_COMPARATOR): ciprofloxacin

Based on this trial design, predict the completion outcome and termination type (if applicable).